SnapShot: Breast Cancer

Cancer Cell

Volumn 22, Issue 4, 2012, Pages

  Polyak, Kornelia ^a   Metzger Filho, Otto ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UVOMORULIN;

BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CELL GROWTH; CELL MEMBRANE; CELL METABOLISM; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; COWDEN SYNDROME; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; MOLECULAR WEIGHT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

EID: 84867617023     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.06.021     Document Type: Short Survey

References (9)

1. Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K.K., Carter, S.L., Frederick, A.M., Lawrence, M.S., Sivachenko, A.Y., Sougnez, C., Zou, L., et al. (2012). Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405-409.
2. Curtis, C., Shah, S.P., Chin, S.F., Turashvili, G., Rueda, O.M., Dunning, M.J., Speed, D., Lynch, A.G., Samarajiwa, S., Yuan, Y., et al.; METABRIC Group; Co-chairs; Writing committee; Steering committee; Tissue and clinical data source sites; University of Cambridge/Cancer Research UK Cambridge Research Institute; British Columbia Cancer Agency; University of Nottingham; King's College London; Manitoba Institute of Cell Biology; Cancer genome/transcriptome characterization centres; University of Cambridge/Cancer Research UK Cambridge Research Institute; British Columbia Cancer Agency; Data analysis subgroup; University of Cambridge/Cancer Research UK Cambridge Research Institute; British Columbia Cancer Agency (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352.
3. Ellis, M.J., Ding, L., Shen, D., Luo, J., Suman, V.J., Wallis, J.W., Van Tine, B.A., Hoog, J., Goiffon, R.J., Goldstein, T.C., et al. (2012). Whole genome analysis informs breast cancer response to Aromatase inhibition. Nature 486, 353-360.
4. Higgins, M.J., and Baselga, J. (2011). Targeted therapies for breast cancer. J. Clin. Invest. 121, 3797-3803.
5. Shah, S.P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012). The clonal and mutational evolution spectrum of primary triplenegative breast cancers. Nature 486, 395-399.
6. Sjöblom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D., Mandelker, D., Leary, R.J., Ptak, J., Silliman, N., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274.
7. Stephens, P.J., Tarpey, P.S., Davies, H., Van Loo, P., Greenman, C., Wedge, D.C., Zainal, S.N., Martin, S., Varela, I., Bignell, G.R., et al. (2012). The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404.
8. TCGA (The Cancer Genome Atlas Network) (2012). Comprehensive molecular portraits of human breast tumors. Nature 490, 61-70.
9. Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjöblom, T., Leary, R.J., Shen, D., Boca, S.M., Barber, T., Ptak, J., et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113.